The study was approved by the Ethics Committee of Showa University (Approval number 3292
Weight loss outcomes with telemedicine during COVID-19
In the last few years, a new class of medications called GLP-1s captured the attention of celebrities and the public alike
Gunja Parikh, MS, RDN, LDN As a registered dietitian, Ive seen firsthand how GLP-1 receptor agonists (GLP-1s) like Semaglutide and Tirzepatide can support weight loss and improve metabolic health for women
Giving patients more realistic expectations of their potential for weight loss could save time, frustration, and money spent learning whether a drug works
These medications imitate the natural hormone GLP-1 (glucagon-like peptide-1), which prompts the pancreas to release insulin